Abstract: A maxilla holder includes a base plate and a connecting member. One end of the connecting member is connected with the base plate which extends along a pre-designed occlusal plane while the other end of the connecting member includes at least two supporting portions. With the supporting portions abutting against the cranium, the base plate is positioned so that the maxilla is located in a pre-planned position once it is moved onto the base plate.

Abstract: A pulmonary function identifying and treating method includes: obtaining a first image, having first image elements, and a second image, having second image elements, respectively corresponding to a first state and a second state of a lung; extracting first feature points of the first image and second feature points of the second image; registering the first image with the second image using a boundary point set registration method and an inner tissue registration method according to the first feature points and the second feature points, so that the first image elements correspond to the second image elements and tissue units of the lung; determining functional index values representative of the tissue units of the lung using a ventilation function quantification method according to the first image elements and the second image elements corresponding to the first image elements; and treating the lung according to the functional index values.

Abstract: A fibroblast activation protein (FAP) compound or salt is provided with albumin dual-binding function. It is a new target FAP molecule, comprising a payload group, a linker group and a FAP binding group. The linker group has an architecture selected from four architectures to connect to the payload group and the FAP binding group to form the FAP compound. The target FAP molecule has the biological activity of binding to albumin in blood and that of binding to FAP protein. The present invention is combined with radioactive nuclide Lu-177, Ac-225, Ga-67 or In-111 for long-circulation FAP targeting in the body. Higher accumulation in expressing FAP tumors is achieved, and the accumulation time of inhibitors in tumors is prolonged. The present invention allows radioactivity to act in the tumor for a long time, thereby reducing the radioactivity concentration or reducing the frequency of radioactive inhibitor administration to inhibit tumor growth.

Abstract: A magnetic traction device for impacted tooth, comprising a first magnetic component fixed to a normal tooth and a second magnetic component fixed to an impacted tooth. There is an attractive magnetic force between the first and second magnetic components, thereby pulling the impacted tooth toward the direction of the normal tooth where the first magnetic component is located.

Abstract: A bone fixation assembly includes a bone plate, a first bone screw and a second bone screw. The first and second bone screws penetrate through two holes respectively. The first bone screw has a left-handed thread while the second bone screw has a right-handed thread. With different thread directions of the bone screws, the bone screws are hard to be loosened so that broken bones are fixed firmly. Accordingly, size of the bone plate is able to be reduced for miniaturization.

Abstract: A maxilla holder includes a base plate and a connecting member. One end of the connecting member is connected with the base plate which extends along a pre-designed occlusal plane while the other end of the connecting member includes at least two supporting portions. With the supporting portions abutting against the cranium, the base plate is positioned so that the maxilla is located in a pre-planned position once it is moved onto the base plate.

Abstract: A dental instrument includes a handle and an extension portion, the extension portion has a frontal protrusion that is used to hang an elastic traction ligature. An impacted tooth traction device includes a first bracket for being fastened to an impacted tooth, and a second bracket for being fastened to an anchor body, and the aforementioned elastic traction ligature that is used to connect the first bracket with the second bracket. A method for installing the impacted tooth traction device includes: fastening the first bracket to the impacted tooth, fastening the second bracket to the anchor body, and to connect the elastic traction ligature to the first and the second brackets after the elastic traction ligature is pulled to a certain length.

Abstract: A pulmonary function identifying method includes: obtaining a first image, having first image elements, and a second image, having second image elements, respectively corresponding to a first state and a second state of a lung; extracting first feature points of the first image and second feature points of the second image; registering the first image with the second image using a boundary point set registeration method and an inner tissue registeration method according to the first feature points and the second feature points, so that the first image elements correspond to the second image elements and tissue units of the lung; and determining functional index values representative of the tissue units of the lung using a ventilation function quantification method according to the first image elements and the second image elements corresponding to the first image elements.

Abstract: High-efficiency control technology for non-volatile memory. A non-volatile memory has single level cells (SLCs) and multiple level cells (e.g., MLCs or TLCs) and is controlled by a controller. According to the controller at the device end, a host allocates a system memory to provide a host memory buffer (HMB). The controller at the device end uses the HMB to buffer write data issued by the host, and then flushes the write data from the HMB to multi-level cells of the non-volatile memory without passing single level cells of the non-volatile memory to reduce write amplification problems due to the frequent use of the single-level cells.

Abstract: Multi-channel accessing of non-volatile memory. A controller uses three kinds of tables to manage cross-channel accessing areas and, accordingly, to access the non-volatile memory through multiple channels. Each cross-channel accessing area includes M storage units, where M is an integer greater than 1. For each cross-channel accessing area, the first table marks whether there is a need for storage unit substitution and points to substitution information. The substitution information is stored in the second table and the third table. For each cross-channel accessing area marked in the first table, the second table stores M bits corresponding to M storage units of the marked cross-channel accessing area for substitution indication, and related substitute storage unit indication is stored in the third table.

Abstract: High-efficiency control technology for non-volatile memory. A non-volatile memory has single level cells (SLCs) and multiple level cells (e.g., MLCs or TLCs) and is controlled by a controller. According to the controller at the device end, a host allocates a system memory to provide a host memory buffer (HMB). The controller at the device end uses the HMB to buffer write data issued by the host, and then flushes the write data from the HMB to multi-level cells of the non-volatile memory without passing single level cells of the non-volatile memory to reduce write amplification problems due to the frequent use of the single-level cells.

Abstract: Multi-channel accessing of non-volatile memory. A controller uses three kinds of tables to manage cross-channel accessing areas and, accordingly, to access the non-volatile memory through multiple channels. Each cross-channel accessing area includes M storage units, where M is an integer greater than 1. For each cross-channel accessing area, the first table marks whether there is a need for storage unit substitution and points to substitution information. The substitution information is stored in the second table and the third table. For each cross-channel accessing area marked in the first table, the second table stores M bits corresponding to M storage units of the marked cross-channel accessing area for substitution indication, and related substitute storage unit indication is stored in the third table.

Abstract: The present invention relates to a method for preparing 186/188Re-labeled human serum albumin (HSA) microspheres by 186/188Re(I)-tricarbonyl ion. This radioactive particle can be subjected to radioembolization for liver tumor. In this method, 186/188Re(I)-tricarbonyl ion (186/188Re(OH2)3(CO)3)+) are employed as a precursor for directly labeling HSA microspheres with 186/188Re at appropriate temperature.

Abstract: The present invention relates to a method for preparing 186/188Re-labeled human serum albumin (HSA) microspheres by 186/188Re(I)-tricarbonyl ion. This radioactive particle can be subjected to radioembolization for liver tumor. In this method, 186/188Re(I)-tricarbonyl ion (186/188Re(OH2)3(CO)3)+) are employed as a precursor for directly labeling HSA microspheres with 186/188Re at appropriate temperature.

Abstract: This invention is to manufacture a kit for preparation of nano-targeted liposome drugs in combined chemotherapy and radionuclide therapy. It is a kit consisting of three components: (1) A 10 ml vial A which contains BMEDA, gluconate acetate, SnCl2. (2) A 10 ml vial B which contains DSPC, cholesterol, DSPE-PEG, and Doxorubicin(DXR) (or Daunorubicin, Vinolbine). (3) A 10 ml vial C which contains 188ReO4? (or 186ReO4?) solution. The procedure of using the kit is as follows: (1) Remove the contents of the 188ReO4? (or 186ReO4?) solution from vial C. (2) Inject the 188ReO4? (or 186ReO4?) solution into the vial A, and the mixtures react in appropriate temperature. (3) Remove the contents of the 188Re-BMEDA (or 186Re-BMEDA) solution from vial A. (4) Inject the 188Re-BMEDA (or 186Re-BMEDA) solution into the vial B, and the mixtures react in appropriate temperature. The reconstituted solution in the vial B is applied to combine bimodality radiochemotherapy for treatment of tumor and ascites.